Active teams
Autologous cell-based therapy for coagulation factor deficiency
- Project leader: Giacomo Roman, Department of Haematology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital
-
Team members: Maria E. Chollet (UiO/OUS), Anindita Bhattacharya (UiO/OUS), Knut Lauritzen (UiO/OUS), Christian Qvigstad (UiO/OUS), Gareth Sullivan (OUS), Per Morten Sandset (UiO/OUS), Benedicte Stavik (OUS)
Blood-based test for solid cancer early detection
- Project leader: Carmen Herrera, Section for Biochemistry and Molecular Biology, Department of Biosciences, University of Oslo
- Team members: P?l Falnes (UiO) and UiO Growth House
Ligament balancing in total knee arthroplasty - a systematic approach to Bellemans technique
- Project leader: Lars Engseth, Department of Orthopaedics - Ullev?l, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital
- Team members: Stephan R?hrl (OUS/UiO), J?rgen Gr?nsund (UiS/Moreld Capnor)
EvoMab: germinal center guided affinity maturation of therapeutic antibodies
- Project leader: Johanne Jacobsen, Department of Immunology, Institute of Clinical Medicine, University of Oslo
- Team member: Valgerdur Bj?rnsdottir (UiO)
Mathematical biomarkers to predict treatment response in breast cancer
- Project leader: Leonard Schmiester, Department of Biostatistics Institute of Basic Medical Sciences, University of Oslo
- Team members: Alvaro K?hn-Luque (OUS), Arnoldo Frigessi (UiO/OUS), Aleix Prat (Hospital Clinic Barcelona), Fara Brasó-Maristany (Hospital Clinic Barcelona), Vessela Kristensen (OUS/UiO), Youness Azimzade (UiO)
PharmaChip
- Project leader:Steven Ray Wilson, Section for Chemical Life Sciences - Biomolecules, Bio-inspired Materials and Bioanalytics, University of Oslo
- Team members: Fr?ydis Sved Skottvoll (SINTEF), Aleksandra Aizenshtadt (UiO), Stefan Krauss (UiO/OUS), Stig Pedersen-Bjergaard (UiO), Michal Mielnik (SINTEF)
DUCT chip – An artificial bile duct on a chip recapitulating immune functions
- Project leader: Henry Hoyle, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital and Institute of Clinical Medicine, UiO
- Team members: Anna Katharina Frank (OUS), Espen Melum (OUS/UiO), Stefan Krauss (UiO/OUS), Mathias Busek (UiO), Aleksandra Aizenshtadt (UiO) and Kayoko Shoji (UiO)
Novel vaccine platform for animal health
- Project leader: Hanne Winther-Larsen, Institute of Pharmacy, UiO
- Team members: Saranya Subramani (UiO) and Aina Rengmark (Inven2)
Experimental-computational platform for antibody-target design
- Project leader: Puneet Rawat, Institute of Clinical Medicine, Dept. of Immunology, UiO
- Team members: Professor Victor Greiff (UiO/OUS), Professor Jan Terje Andersen (UiO/OUS), Dr. Fridtjof Lund-Johansen (OUS/UiO)
Development of engineered NK-EVs for Targeted Therapy in Breast Cancer
- Project leader: Yunjie Wu, Faculty of Medicine, Institute of Clinical Medicine, Dept. of Pharmacology, UiO
- Team members: Linlin Song (OUS), J?rgen Wesche (OUS/UiO) and Marit Inngjerdingen (OUS/UiO)
Personalized Rapid Ex vivo Determination of Immunotherapeutic Cancer Treatment (PREDICT)
- Project leader: Audun Kvalvaag, Institute for Cancer Research, Oslo University Hospital
- Team members: Dr. Ieva Ailte (OUS) and Professor Harald Stenmark (OUS/UiO)
p95HER2-CAR T cell targeting metastatic breast cancer on-Target, but no off-Tumor
- Project leader: Esmaeil Dorraji, Institute for Cancer Research, Radium Hospital, Oslo University Hospital
- Team members: Jon Amund Kyte, Aina Rengmark, Eivind Roverud, Magdalena Gjefle and Bj?rn Naume
Targeting the TREM2-receptor for Alzheimer’s disease therapy 
- Project leader: Lars Nilsson, Pharmacology, Institute of Clinical Medicine, UiO
- Team members: Vibeke ?rskog, Sandra Kühn, Jo Klaveness
rOoC (revolving Organ-on-chip platform)
- Project leader: Dr. Alexandra Aizenshtadt, Centre of Excellence - Hybrid Technology Hub, University of Oslo
- Team members: Dr. Mathias Busek, Chencheng Wang, Prof. Steven Ray Haakon Wilson, Prof. Stefan Krauss, Dr. Hanne Scholz
Novel targets for attenuating disease progression in Parkinson’s disease
- Project leader: Nicola Pietro Montaldo, Dept. of Microbiology, Division of Laboratory Medicine, University of Oslo
- Team members: Prof. Hilde Nilsen, Francisco G Naranjo, Kulbhushan Sharma, Swapnil Gupta, Torkild Visnes
Cancer Stem Cell Prognostics in Patient Prostate Tumor Organoids
- Project leader: Adam Filipczyk, Div. of Laboratory Medicine, Oslo University Hospital
- Team members: Carsten Marr, Arne Klungland, Kyrre Eeg Emblem, Rune Ougland
Broadly reactive vaccines against seasonal infectious disease 
- Project leader: Kristin Lunder Klausen PhD candidate, University of Oslo and Oslo University Hospital
- Team member: Dr. Gunnveig Gr?deland, UiO
Tankyrase inhibition for therapy of fibrotic diseases
- Project leader: Shoshy Alam Brinch, Hybrid Technology Hub, UiO and Department of Immunology and Transfusion Medicine, Oslo University Hospital
- Team members: Jo Waaler (OUS/UiO) and Stefan Krauss (UiO/OUS)
Novel Treatment for Patients with Glioblastoma
- Project leader: Postdoc Aleksandra Dukic, Institute of Clinical Medicine, UiO and Institute for Cancer Research, Oslo University Hospital
- Team members: Professor Kjetil Taskén, Associate Professor Rafi Ahmad and Inven2